There have been 50 recent insider transactions recorded for bluebird bio, Inc. (BLUE), including 13 buys and 37 sells. Total insider buying was valued at $359.8K and total insider selling at $227.58K.
Notable insiders with recent activity include Vittiglio Joseph, Leschly Nick, Vachon Mark. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.
Insider Transactions — BLUE
| Date |
Name |
Role |
Transaction |
Shares |
Avg. Price |
Value |
Shares Owned |
| 2025-06-02 |
Vittiglio Joseph |
Chief Business & Legal Officer |
Return of Shares |
2,500 |
$3.00 |
$7.5K |
- |
| 2025-06-02 |
Leschly Nick |
Director |
Return of Shares |
1,245 |
$3.00 |
$3.74K |
- |
| 2025-06-02 |
Vachon Mark |
Director |
Return of Shares |
1,245 |
$3.00 |
$3.74K |
- |
| 2025-06-02 |
Agwunobi John O |
Director |
Return of Shares |
1,245 |
$3.00 |
$3.74K |
- |
| 2025-06-02 |
Klima Thomas J |
See Remarks |
Return of Shares |
2,500 |
$3.00 |
$7.5K |
- |
| 2025-06-02 |
Cloonan Michael |
Director |
Return of Shares |
1,867 |
$3.00 |
$5.6K |
- |
| 2025-06-02 |
Paulson Richard A. |
Director |
Return of Shares |
1,323 |
$3.00 |
$3.97K |
- |
| 2025-06-02 |
Obenshain Andrew |
President and CEO |
Return of Shares |
14,820 |
$3.00 |
$44.46K |
- |
| 2025-06-02 |
Leiderman Elisabeth |
Director |
Return of Shares |
1,245 |
$3.00 |
$3.74K |
- |
| 2025-06-02 |
Sterling O. James |
Chief Financial Officer |
Return of Shares |
2,500 |
$3.00 |
$7.5K |
- |
| 2025-06-02 |
Tita-reid Najoh |
Director |
Return of Shares |
1,245 |
$3.00 |
$3.74K |
- |
| 2025-06-02 |
Jones-burton Charlotte |
Director |
Return of Shares |
1,245 |
$3.00 |
$3.74K |
- |
| 2025-06-02 |
Colvin Richard A |
Chief Medical Officer |
Return of Shares |
2,500 |
$3.00 |
$7.5K |
- |
| 2025-05-30 |
Vittiglio Joseph |
Chief Business & Legal Officer |
Tender Offer (Sell) |
1,143 |
$3.00 |
$3.43K |
3,125 |
| 2025-05-30 |
Leschly Nick |
Director |
Tender Offer (Sell) |
6,150 |
$3.00 |
$18.45K |
- |
| 2025-05-30 |
Vachon Mark |
Director |
Tender Offer (Sell) |
1,252 |
$3.00 |
$3.76K |
1,245 |
| 2025-05-30 |
Agwunobi John O |
Director |
Tender Offer (Sell) |
1,323 |
$3.00 |
$3.97K |
1,245 |
| 2025-05-30 |
Klima Thomas J |
See Remarks |
Tender Offer (Sell) |
3,414 |
$3.00 |
$10.24K |
4,464 |
| 2025-05-30 |
Paulson Richard A. |
Director |
Tender Offer (Sell) |
155 |
$3.00 |
$465.00 |
1,323 |
| 2025-05-30 |
Obenshain Andrew |
President and CEO |
Tender Offer (Sell) |
9,027 |
$3.00 |
$27.08K |
9,300 |
| 2025-05-30 |
Leiderman Elisabeth |
Director |
Tender Offer (Sell) |
1,112 |
$3.00 |
$3.34K |
1,245 |
| 2025-05-30 |
Tita-reid Najoh |
Director |
Tender Offer (Sell) |
1,163 |
$3.00 |
$3.49K |
1,245 |
| 2025-05-30 |
Jones-burton Charlotte |
Director |
Tender Offer (Sell) |
928 |
$3.00 |
$2.78K |
1,245 |
| 2025-05-30 |
Colvin Richard A |
Chief Medical Officer |
Tender Offer (Sell) |
3,552 |
$3.00 |
$10.66K |
4,166 |
| 2025-03-03 |
Klima Thomas J |
See Remarks |
Informative Sell |
500 |
$3.92 |
$1.96K |
7,878 |
| 2025-03-03 |
Obenshain Andrew |
President and CEO |
Informative Sell |
921 |
$3.92 |
$3.61K |
18,327 |
| 2025-03-03 |
Colvin Richard A |
Chief Medical Officer |
Informative Sell |
584 |
$3.92 |
$2.29K |
7,610 |
| 2025-02-10 |
Obenshain Andrew |
President and CEO |
RSU Award |
763 |
- |
- |
19,248 |
| 2025-02-03 |
Vittiglio Joseph |
Chief Business & Legal Officer |
Informative Sell |
238 |
$7.39 |
$1.76K |
4,501 |
| 2025-02-03 |
Klima Thomas J |
See Remarks |
Informative Sell |
122 |
$7.39 |
$901.89 |
8,378 |
| 2025-02-03 |
Obenshain Andrew |
President and CEO |
Informative Sell |
86 |
$7.39 |
$635.76 |
18,485 |
| 2025-02-03 |
Colvin Richard A |
Chief Medical Officer |
Informative Sell |
64 |
$7.39 |
$473.12 |
8,194 |
| 2025-01-06 |
Obenshain Andrew |
President and CEO |
Informative Sell |
140 |
$9.24 |
$1.29K |
18,571 |
| 2025-01-06 |
Colvin Richard A |
Chief Medical Officer |
Informative Sell |
19 |
$9.24 |
$175.56 |
8,257 |
| 2024-12-10 |
Obenshain Andrew |
President and CEO |
Informative Sell |
971 |
$0.42 |
$405.20 |
374,247 |
| 2024-12-10 |
Colvin Richard A |
Chief Medical Officer |
Informative Sell |
2,824 |
$0.42 |
$1.18K |
165,544 |
| 2024-11-06 |
Leschly Nick |
Director |
RSU Award |
49,850 |
$0.44 |
$21.93K |
49,850 |
| 2024-11-06 |
Vachon Mark |
Director |
RSU Award |
49,850 |
$0.44 |
$21.93K |
49,850 |
| 2024-11-06 |
Agwunobi John O |
Director |
RSU Award |
49,850 |
$0.44 |
$21.93K |
49,850 |
| 2024-11-06 |
Paulson Richard A. |
Director |
RSU Award |
24,900 |
- |
- |
29,563 |
| 2024-11-06 |
Leiderman Elisabeth |
Director |
RSU Award |
24,900 |
- |
- |
47,156 |
| 2024-11-06 |
Tita-reid Najoh |
Director |
RSU Award |
24,900 |
- |
- |
48,160 |
| 2024-11-06 |
Jones-burton Charlotte |
Director |
RSU Award |
24,900 |
- |
- |
43,462 |
| 2024-09-30 |
Vittiglio Joseph |
Chief Business & Legal Officer |
RSU Award |
50,000 |
- |
- |
94,783 |
| 2024-09-30 |
Klima Thomas J |
See Remarks |
Informative Sell |
1,006 |
$0.53 |
$528.85 |
170,000 |
| 2024-09-30 |
Cloonan Michael |
Director |
RSU Award |
37,350 |
- |
- |
37,350 |
| 2024-09-30 |
Obenshain Andrew |
President and CEO |
Informative Sell |
34,780 |
$0.53 |
$18.27K |
375,218 |
| 2024-09-30 |
Sterling O. James |
Chief Financial Officer |
RSU Award |
100,000 |
- |
- |
100,000 |
| 2024-09-30 |
Colvin Richard A |
Chief Medical Officer |
RSU Award |
50,000 |
- |
- |
168,368 |
| 2024-07-01 |
Sterling O. James |
Chief Financial Officer |
RSU Award |
300,000 |
$0.98 |
$294K |
300,000 |
■ Informative Buy/Sell — open market transaction (most significant)
■ Uninformative Buy — award, option exercise, conversion
■ Uninformative Sell — tax withholding, award vest sale
■ Neutral — gift, trust, expiry
